Citation: Ej. Mcconnell et al., IRREVERSIBLE INHIBITION OF PLASMA-MEMBRANE (CA2-ATPASE AND CA2+ TRANSPORT BY 4-HYDROXYNONENAL(+MG2+)), The FASEB journal, 12(5), 1998, pp. 4789-4789
Citation: Bu. Raess et al., EFFECTS OF 4-OH-2,3-TRANS-NONENAL ON HUMAN ERYTHROCYTE PLASMA-MEMBRANE CA2+ PUMP AND PASSIVE CA2+ PERMEABILITY, Biochemical and biophysical research communications, 235(3), 1997, pp. 451-454
Citation: Bu. Raess et Ce. Keenan, 4-HYDROXYNONENAL MODIFICATION OF ACTIVE CA2-ATPASE ACTIVITIES AND PASSIVE CA2+ PERMEABILITY OF HUMAN ERYTHROCYTES( TRANSPORT, (CA2++MG2+)), The FASEB journal, 10(3), 1996, pp. 3754-3754
Citation: Gk. Matheson et al., EFFECTS OF REPEATED DOSES OF AZAPIRONES ON RAT-BRAIN 5-HT1A RECEPTORSAND PLASMA-CORTICOSTERONE LEVELS, General pharmacology, 27(2), 1996, pp. 355-361
Citation: Bu. Raess et Ce. Keenan, CHARACTERIZATION OF A PHENYLGLYOXAL-SENSITIVE PASSIVE CA2+ PERMEABILITY IN HUMAN ERYTHROCYTES, The Journal of membrane biology, 151(1), 1996, pp. 45-51
Citation: Bu. Raess et Ce. Keenan, CHARACTERIZATION OF A PASSIVE ERYTHROCYTE CA2+ PERMEABILITY AND ITS PHARMACOLOGICAL MODIFICATION BY PHENYLGLYOXAL, The FASEB journal, 9(3), 1995, pp. 366-366
Citation: Bu. Raess et al., REGULATION OF RABBIT ERYTHROCYTE CA2-PUMP SENSITIVITY TO CALMODULIN IN EXPERIMENTAL HYPERLIPIDEMIA(), Proceedings of the Society for Experimental Biology and Medicine, 209(4), 1995, pp. 410-417